PF-30685 |
STOCRIN MSD 600 mg comprimidos recubiertos |
2008-06-03 |
|
Merck & Co Inc. |
Estados Unidos de América
|
Colon S.A. |
Agencias J.i. Cohen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31631 |
VIDEX 25 mg Tabletas Amortiguadas, masticables/dispersables |
2008-11-17 |
|
Bristol-myers Squibb U.s. Pharmaceutical Group |
Estados Unidos de América
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31633 |
VIDEX 150 mg Tabletas Amortiguadas, masticables/dispersables |
2008-11-17 |
|
Bristol-myers Squibb U.s. Pharmaceutical Group |
Estados Unidos de América
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31646 |
VIDEX 100 mg Tabletas Amortiguadas, masticables/dispersables |
2008-11-20 |
|
Bristol-myers Squibb U.s. Pharmaceutical Group |
Estados Unidos de América
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-32048 |
REYATAZ 150 mg Capsulas |
2009-02-02 |
|
Bristol-myers Squibb U.s. Pharmaceutical Group |
Estados Unidos de América
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-32049 |
REYATAZ 200 mg Capsulas |
2009-02-02 |
|
Bristol-myers Squibb U.s. Pharmaceutical Group |
Estados Unidos de América
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-32047 |
REYATAZ 100 mg Capsulas |
2009-02-02 |
|
Bristol-myers Squibb U.s. Pharmaceutical Group |
Estados Unidos de América
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-32329 |
VIDEX 50 mg Tabletas amortiguadas, masticables/dispersables |
2009-03-16 |
|
Bristol-myers Squibb U.s. Pharmaceutical Group |
Estados Unidos de América
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-19620 |
Aprovel 75 mg tabletas |
2003-03-12 |
|
Sanofi Synthelabo De Guatemala, S.A. |
Guatemala
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-19632 |
Avapro 300 mg tabletas |
2003-03-16 |
|
Bristol Myers Squibb De Guatemala Ltda. |
Guatemala
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|